1 active not recruiting, 1 terminated, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Terminated 1, Withdrawn 1 |
Follow Peritoneal Carcinoma: new trials by email Literature Review of Peritoneal Carcinoma trials Research Report on Peritoneal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma DCVAC/OvCa, DCVAC/OvCa placebo - Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Withdrawn | SOTIO a.s. | 2021-08-01 | 2021-12-23 | |
| Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery Oregovomab, Paclitaxel, Carboplatin - Carcinoma, Ovarian Epithelial, Ovarian Neoplasms | Phase 3 | Active not recruiting | CanariaBio Inc. | 615 | 2020-08-25 | 2026-04-01 |
| Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer Interferon gamma-1b - Ovarian Carcinoma, Peritoneal Carcinoma | Phase 3 | Terminated | InterMune | 847 | 2001-10-01 | 2007-11-01 |
Ovarian Neoplasms (3) · Fallopian Tube Neoplasms (2) · Carcinoma (1) · Carcinoma, Ovarian Epithelial (1) · Neoplasms (1) · Peritoneal Neoplasms (1)
Adnexal Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Gonadal Disorders (3) · Neoplasms by Site (3) · Ovarian Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Fallopian Tube Diseases (2) · Neoplasms (2)
Carboplatin (1) · Paclitaxel (1) · interferon gamma-1b (1) · oregovomab (1)
CanariaBio Inc. (1) · InterMune (1) · SOTIO a.s. (1)
United States (2) · Argentina (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Czechia (1) · Hungary (1) · India (1) · Italy (1) · Mexico (1) · South Korea (1) · Spain (1) · Taiwan (1)
David Cibula, Prof. MD PhD (1) · Harald Fricke, MD PhD (1) · Sunil Gupta, MD, FRCPC (1)